CD8A and autoimmune disease: CD8+CD28− T cells with a regulatory phenotype have been observed in patients having undergone successful organ transplantation (69–71), alloanergized HLA-mismatched bone marrow graft (72), and allogenic platelet transfusion (73) or suffering from autoimmune diseases (74–76), pregnancy complications (77), and cancers (78–80).